Rxo (RXO) Asset Writedowns and Impairment (2024 - 2026)

Rxo (RXO) has reported Asset Writedowns and Impairment for 3 consecutive years, with $4.0 million the latest figure, recorded in Q1 2026.

• Asset Writedowns and Impairment for Q1 2026 came in at $4.0 million, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $22.0 million (changed N/A YoY), and the FY2025 annual result was $4.0 million, down 69.23% from the prior year.
• Asset Writedowns and Impairment was $4.0 million for Q1 2026 at Rxo, up from $1.0 million in the prior quarter.
• Over five years, Asset Writedowns and Impairment peaked at $13.0 million in Q4 2024 and troughed at $1.0 million in Q4 2025.
• Average Asset Writedowns and Impairment over 3 years is $5.5 million, with a median of $4.0 million recorded in 2025.
• Year-over-year, Asset Writedowns and Impairment sank 92.31% in 2025 and changed 0.0% in 2026.
• Over 3 years, Asset Writedowns and Impairment stood at $13.0 million in 2024, then tumbled by 92.31% to $1.0 million in 2025, then jumped by 300.0% to $4.0 million in 2026.
• Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $4.0 million in Q1 2026, $1.0 million in Q4 2025, and $4.0 million in Q1 2025.